Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Outcomes of Post-Transplant Cyclophosphamide Prophylaxis in Matched Sibling Donor Allogeneic Hematopoietic Cell Transplant: A Retrospective Study at a Single Tertiary Center in Saudi Arabia

Alaa Eldein Yahia, Abdullah Alsakkaf, Faisal Abdullah Alshehri, Zahra AlHaj Issa, Aws A. Alsuhaibani, Jude Howaidi, Abdullah M. Alrajhi, Bilal Albtoosh, Gamal Mohamed, Ammar Hasan Alsughayir, Mohammed S Alnoamani, Kamal Alzahrani, Nawal F Alshehry, Imran K Tailor, Mohammed Marei, Ibraheem H Motabi, Muhned Alhumaid, Hassan Alshehri

Blood (2024) 144 (Supplement 1): 7316.

https://doi.org/10.1182/blood-2024-206866

Published: 2024

Journal Articles

Effectiveness of Nivolumab with ICE Protocol in Relapsed or Refractory Hodgkin Lymphoma: A Single-Center Experience from Riyadh, Saudi Arabia

Abdullah Alsakkaf, Alaa Eldein Yahia, Asim A Alharbi, Abdullah M. Alrajhi, Tahani Alhalouly, Bilal Albtoosh, Kamal Alzahrani, Mohammed S Alnoamani, Muhned Alhumaid, Hassan Alshehri, Nawal F Alshehry, Ibraheem H Motabi, Mohammed Marei, Imran K Tailor

Blood (2024) 144 (Supplement 1): 6376.

https://doi.org/10.1182/blood-2024-204017

Published: 2024

Journal Articles

Bleomycin Induced Lung Toxicity in Hodgkin Lymphoma Patients Treated with ABVD Regimen- a Single Center Experience from Riyadh, Saudi Arabia

Alaa Eldein Yahia, Abdullah Alsakkaf, Hassan Alshehri, Nawal F Alshehry, Abdullah M. Alrajhi, Bilal Albtoosh, Tahani Alhalouly, Mohammed S Alnoamani, Muhned Alhumaid, Kamal Alzahrani, Mohammed Marei, Ibraheem H Motabi, Imran K Tailor

Blood (2024) 144 (Supplement 1): 6374.

https://doi.org/10.1182/blood-2024-203962

Published: 2024

Journal Articles

Bv-AVD Esclation after Partial Response to ABVD Chemotherapy in Patinets with HL: A Retrospective Study

Amani Almuqbil, Abdullah Alrajhi, Hassan Alshehri, Ibraheem H Motabi, Imran K Tailor, Kamal Alzahrani, Mohammed Marei, Mohammed S Alnoamani, Nawal F Alshehry, Muhned Alhumaid

Blood (2024) 144 (Supplement 1): 6373.

https://doi.org/10.1182/blood-2024-203089

Published: 2024

Journal Articles

Outcomes of Secondary CNS Lymphoma with Carmustine/Thiotepa Conditioning and Autologous Stem Cell Transplant-a Case Series from Single Center, Saudi Arabia

Zakarya Bahaliwah, Alaa Eldein Yahia, Abdullah Alsakkaf, Tahani Alhalouly, Kamal Alzahrani, Ammar Hasan Alsughayir, Mohammed S Alnoamani, Hassan Alshehri, Nawal F Alshehry, Muhned Alhumaid, Mohammed Marei, Ibraheem H Motabi, Imran K Tailor

Blood (2024) 144 (Supplement 1): 6446.

https://doi.org/10.1182/blood-2024-204789

Published: 2024

Journal Articles

Prognostic Value of Interim PET/CT in Predicting Outcomes of Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP Therapy: A Retrospective Analysis from Single Centre, Riyadh, Saudi Arabia

Asim A Alharbi, Abdullah Alsakkaf, Abdullah M. Alrajhi, Tahani Alhalouly, Bilal Albtoosh, Kamal Alzahrani, Mohammed S Alnoamani, Hassan Alshehri, Nawal F Alshehry, Ibraheem H Motabi, Mohammed Marei, Muhned Alhumaid, Imran K Tailor

Blood (2024) 144 (Supplement 1): 6439.

https://doi.org/10.1182/blood-2024-208523

Published: 2024

Journal Articles

Efficacy and Safety of AALL0232 Protocol in Adults with Acute Lymphoblastic Leukemia: Single Institution Experience

Abdullah M. Alrajhi, Mashael Alrouqi, Jude Howaidi, Mohammmad Alwadi, Hassan Alshehri, Imran K Tailor, Mohammed S Alnoamani, Nawal F Alshehry, Ibraheem H Motabi, Mohammed A Marei, Muhned Alhumaid

Blood (2023) 142 (Supplement 1): 7367.

https://doi.org/10.1182/blood-2023-189082

Published: 2023

Journal Articles

Blinatumomab with Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review

Blood (2023) 142 (Supplement 1): 5889.

https://doi.org/10.1182/blood-2023-180221

Published: 2023

Journal Articles

JAK2 GGCC (46/1) Haplotype in Unprovoked Venous Thrombotic Events

Maged Al-Ammari, Abdul Ali Peer Zada, Ibraheem H. Motabi, Belal M. Albtoosh, Syed Y. Altaf, Imran K. Tailor, Mohammed S. Alnoamani, Syed Ziauddin A Zaidi, Mansour Alfayez, Nawal F Alshehry, Mohammed A. Marei

Blood (2021) 138 (Supplement 1): 4258.

https://doi.org/10.1182/blood-2021-149560

Published: 2021

Journal Articles

Efficacy of Brentuximab Vedotin and Bendamustine Combination in Relapsed/Refractory Hodgkin Lymphoma: Experience from a Tertiary Care Hospital

Abdullah M Alrajhi, Razan A. Aljalali, Lara H. Alghazi, Ibrahim Asiri, Adel Alnakhli, Fouad H. Alnajjar, Nawal F Alshehry, Ibraheem H. Motabi, Mohammed S. Alnoamani, Mohammed A. Marei, Mansour Alfayez, Imran K. Tailor

Blood (2021) 138 (Supplement 1): 4532.

https://doi.org/10.1182/blood-2021-152911

Published: 2021

Journal Articles

Polatuzumab Vedotin As a Salvage Treatment in Relapsed or Refractory DLBCL: Single Center Experience

Marwa Bin Morya, Mohammed A. Marei, Imran K. Tailor, Abdullah M Alrajhi, Adel Alnakhli, Foud Alnajjar, Mohammed S. Alnoamani, Hassan Alshehri, Ibraheem H. Motabi, Nawal AlShehry, Mansour Alfayez

Blood (2021) 138 (Supplement 1): 4558.

https://doi.org/10.1182/blood-2021-150242

Published: 2021

Journal Articles

Safety and Efficacy of Azacitidine with Venetoclax for Newly Diagnosed Intensive Chemotherapy Ineligible, and Relapsed or Refractory Acute Myeloid Leukemia in Arab Population: A Single-Center, Retrospective Study

Mohammmad Alwadi, Jude Howaidi, Abdullah M Alrajhi, Adel Alnakhli, Mohammed A. Marei, Imran K. Tailor, Fouad H. Alnajjar, Syed Y. Altaf, Mohammed S. Alnoamani, Kamal Alzahrani, Hassan Alshehri, Ibraheem H. Motabi, Syed Ziauddin A Zaidi, Nawal F Alshehry, Mansour Alfayez

Blood (2021) 138 (Supplement 1): 4423.

https://doi.org/10.1182/blood-2021-153335

Published: 2021

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Outcomes of Post-Transplant Cyclophosphamide Prophylaxis in Matched Sibling Donor Allogeneic Hematopoietic Cell Transplant: A Retrospective Study at a Single Tertiary Center in Saudi Arabia

Effectiveness of Nivolumab with ICE Protocol in Relapsed or Refractory Hodgkin Lymphoma: A Single-Center Experience from Riyadh, Saudi Arabia

Bleomycin Induced Lung Toxicity in Hodgkin Lymphoma Patients Treated with ABVD Regimen- a Single Center Experience from Riyadh, Saudi Arabia

Bv-AVD Esclation after Partial Response to ABVD Chemotherapy in Patinets with HL: A Retrospective Study

Outcomes of Secondary CNS Lymphoma with Carmustine/Thiotepa Conditioning and Autologous Stem Cell Transplant-a Case Series from Single Center, Saudi Arabia

Prognostic Value of Interim PET/CT in Predicting Outcomes of Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP Therapy: A Retrospective Analysis from Single Centre, Riyadh, Saudi Arabia

Efficacy and Safety of AALL0232 Protocol in Adults with Acute Lymphoblastic Leukemia: Single Institution Experience

Blinatumomab with Tyrosine Kinase Inhibitor for Ph-Positive B-Acute Lymphoblastic Leukemia (B-ALL): Multicenter Retrospective Review

JAK2 GGCC (46/1) Haplotype in Unprovoked Venous Thrombotic Events

Efficacy of Brentuximab Vedotin and Bendamustine Combination in Relapsed/Refractory Hodgkin Lymphoma: Experience from a Tertiary Care Hospital

Polatuzumab Vedotin As a Salvage Treatment in Relapsed or Refractory DLBCL: Single Center Experience

Safety and Efficacy of Azacitidine with Venetoclax for Newly Diagnosed Intensive Chemotherapy Ineligible, and Relapsed or Refractory Acute Myeloid Leukemia in Arab Population: A Single-Center, Retrospective Study

Email alerts

ASH Publications

American Society of Hematology